Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Recombinant newcastle disease virus rAI4-gB vaccine strain expressing infectious laryngotracheitis virus gB protein, and construction method for the vaccine strain

A construction method, a technology for tracheitis, applied in recombinant DNA technology, microorganism-based methods, viruses/phages, etc., can solve the problems of scattered poison, poultry stress, time-consuming and labor-intensive immunization, etc.

Inactive Publication Date: 2014-01-22
YANGZHOU UNIV
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, inactivated vaccines cannot provide sufficient protection, and oil-emulsion adjuvants can cause local adverse reactions, resulting in decreased meat quality and animal discomfort. In addition, there are many types of vaccines that need to be vaccinated during the growth of poultry, and some vaccines need to be administered twice or even multiple times. The immunization of poultry causes stress to the poultry and affects the growth in different degrees; at the same time, the vaccination often interferes with the serological monitoring of the disease. have serious consequences

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant newcastle disease virus rAI4-gB vaccine strain expressing infectious laryngotracheitis virus gB protein, and construction method for the vaccine strain
  • Recombinant newcastle disease virus rAI4-gB vaccine strain expressing infectious laryngotracheitis virus gB protein, and construction method for the vaccine strain
  • Recombinant newcastle disease virus rAI4-gB vaccine strain expressing infectious laryngotracheitis virus gB protein, and construction method for the vaccine strain

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0035] The recombinant Newcastle disease vaccine strain rAI4-gB expressing the gB protein of infectious laryngotracheitis virus of the present invention was preserved on August 5, 2013 in the General Microbiology Center of the China Committee for the Collection of Microorganisms (Address: 1 Beichen West Road, Chaoyang District, Beijing) No. 3, Institute of Microbiology, Chinese Academy of Sciences), classified as Newcastle disease virus rAI4-gB, preservation number CGMCC No: 8053.

[0036] Construction step 1: Construction of a full-length expression clone expressing the gB protein of infectious laryngotracheitis virus using Newcastle disease virus AI4 as a vector

[0037] Biomaterial preparation:

[0038] Full-length expression clone pNDV / AI4 of Newcastle disease virus AI4 strain (Hu Z, Hu S, Meng C, et al. Generation of a Genotype VII Newcastle Disease Virus Vaccine Candidate with High Yield in Embryonated Chicken Eggs. Avian Diseases2011, 55(3) :1759-1769) was constructed ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a recombinant newcastle disease virus (NDV) rAI4-gB vaccine strain expressing an infectious laryngotracheitis virus gB protein, and a construction method for the vaccine strain. The accession number of the newcastle disease virus rAI4-gB vaccine strain is CGMCC No: 8053. The construction method includes inserting a sequence showed as SEQ ID NO.7 into an AI4 genome full-length transcripted vector pNDV / AI4, by utilizing an established reverse genetics operation platform of gene VII-type NDV attenuated AI4 strains, so as to obtain recombinant newcastle disease virus genome full-length cDNA cloned pNDV / AI4-gB comprising the infectious laryngotracheitis virus gB gene. Recombinant virus rAI4-gB obtained by transfection has high reproducing titer in a chick embryo, and is capable of stable expression of the gB protein even after continuous passage and is suitable for large-scale production of the vaccine. The recombinant virus rAI4-gB can be used for manufacturing the vaccine.

Description

technical field [0001] The invention relates to the application of reverse genetic technology to rescue a recombinant vaccine strain rAI4-gB expressing the gB protein of infectious laryngotracheitis virus with Newcastle disease virus as a carrier, and is used for vaccine development. Background technique [0002] Reverse genetics manipulation technique (Reverse genetics manipulation technique) refers to the reverse transcription of RNA virus genomic RNA into cDNA, and the artificial construction of new infectious viruses in vitro by using methods such as gene mutation, gene insertion, gene knockout, and gene replacement. , to study the genome structure and function of the virus and the interaction between the virus host [Conzelmann KK. Also often referred to as "virus rescue". With the establishment of reverse genetic technology for Newcastle disease virus, the "rescued" RNA virus is derived from cDNA clones. Therefore, through the artificially added DNA link in the interme...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N7/01C12N15/38C12N15/63C12R1/93
Inventor 刘秀梵陈坚屠颉吴艳涛王晓泉胡顺林
Owner YANGZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products